INSIGHTS ON DRUG DEVELOPMENT

• The Organ-Chip Portfolio

  Watch to learn about an organ-chip that has been designed to reduce drug absorption while improving biological modeling to provide researchers with enhanced accuracy in forecasting human drug response.

• Overcoming Gene Therapy Cost Roadblocks On The Path To Patients

  Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.

• Assessing Reproductive Health With A Human Vagina-On-A-Chip

  Learn about the development of a Vagina-on-a-Chip model designed to facilitate advanced research into bacterial vaginosis and other diseases from Gautam Mahajan, Ph.D., of Emulate.

• How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

  With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

• Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success

  2/26/2025

  By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

• Step-By-Step Guide To Tech Transfer Preparation And Execution

  10/31/2024

  How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?

• Improved Cell Viability For Multi-Day Cell-Based Assays

  7/24/2025

  Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.

• Benchmarking Filtration Performance Of TFF Cassettes

  5/30/2025

  Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.

• Advanced Therapies Going Mainstream: Are We There Yet?

  11/14/2025

  Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.